2. Case I: 0885957
⢠A 77-yr man
⢠Presented with slow
growing mass at base of
3rd MCP for 2 Yrs
⢠UD CA prostate HT and
COPD
⢠Denied Hx of trauma
⢠Denied Hx of
medication allergy
⢠PE : 4 cm of firm
round, not tender mass
at palmar site of base
3rd MCP joint, slightly
movable
⢠No distal pinprick
sensation deficit
4. Case II: 0470042
⢠55 Yr woman
⢠Mass at 3rd finger right
hand 2 yrs
⢠UD HT
⢠Denied Hx of trauma
⢠Denied Hx of
medication allergy
⢠PE : 2 cm cystic to firm
consistency mass, not
tender at palmar
surface of 3rd
finger, slightly movable
⢠Transillumination test:
negative
⢠No distal pinprick
sensation deficit
5. Case III
⢠43-yr woman
⢠Refered from outer
hospital
⢠Mass at 3rd finger right
hand 2 mth
⢠No UD
⢠Denied Hx of trauma
⢠Denied Hx of
medication allergy
⢠PE : 1 cm firm to hard
consistency mass, not
tender, fixed at palmar
site of right 3rd finger
⢠No limit ROM of right
3rd finger
⢠No distal pinprick
sensation deficit
8. Incidence
⢠Mostly benign in type (80%)
⢠From ASSH information (American Society for Surgery of the
Hand)
â 1.Ganglion cyst
â 2.Giant cell tumour of tendon sheath
â 3.Epidermal inclusion cyst
9. Incidence
⢠Other benign eg.
Enchondroma, osteoma, osteochondroma, Glomus tumour
etc.
⢠Malignancies relatively rare
â Skin is most common
⢠SCCA > BCCA
â Bone is 2nd common
⢠Chondrosarcoma
10. Dx & Ix
⢠Hx taking
â Age
â Hx of tumour eg. duration, change in size or color
or ulceration, pain
â UD such as psoriasis, rheumatoid etc.
â Hx of risk factor eg. Hx of cutanenous
malignancies, sunburn or radiation exposed
11. Dx & Ix
⢠PE : S3 C2 MN
â S ize
â S ite
â S hape
â C olour
â C onsistency
â M obility
â N odes and Imaging
12. Dx & Ix
⢠Lab : up to DDx
⢠Plane X-ray
⢠Accuracy of tissue biopsy
â Frozen section 80%
â Core needle biopsy 83-93%
â Permanent section 96%
13. Ganglion cyst(Neligan&Green)
⢠Woman > man
⢠70% in 20s- 40s
⢠60-70% in Dorsocarpal
â Scapholunate
interrossous ligament
⢠20% Volarcarpal
â Scapho-trapeziotrapezoid interossous
ligament
14. Ganglion cyst
⢠Transillumnation test
positive
⢠Hypothesis formation
â Synovial herniation
â Synovial dermoid
â New growth from
synovial membranes
â Modification bursae or
degenarative cysts
â Mucoid degeneration
15. Ganglion cyst
⢠Choice of treatment (Suen et al. 2013)
⢠Conservative
â Reassure : 40-58% spontanous resolution
â Aspiration : 15% recurrence
â Steroid injection : no benefit
â Sclerotherapy : no benefit
â Hyaluronidase : in conclusive
â Threat technique : 4.8% recurrence 11% infection
16. Ganglion cyst
⢠Choice of treatment (Suen et al. 2013)
⢠Surgery : 1% recurrence rate
⢠Operative technique (Green)
â Dorsal wrist ganglion :
⢠Transverse incision
⢠Open joint capsule to remove small intraarticular cyst
â Volar wrist ganglion :
⢠Longitudinal incision
⢠Beware radial artery
17. Giant Cell Tumour of Tendon Sheath
⢠Pigmented Villonodular
synovitis
⢠Adams et al. 2012
â Woman > men
â 40s â 50s
⢠Slow
growing, firm, nodular,
nontender mass
⢠Mostly on volar site and
DIP joint of 1st-3rd finger
Neligan&Green
19. Epidermal Inclusion Cyst
⢠Invagination of
epithelium after injury
⢠Most common in
fingertip
⢠Some mimic bone lytic
lesion like malignancy
>> biopsy
⢠Rx : Marginal excision
⢠Rare recurrence
Neligan&Green
20. Squamous Cell Carcinoma
⢠Most common malignant tumour in hand
⢠Common in dorsum, chronic sun exposure
area
⢠Askari et al. 2013
â Mean age 69 yr (39-89 yr)
â Overall survival 5yr 88%, 10yr 57%
â Recurrence free survival 5yr 67%, 10yr 50%
â Rate of metastasis 4%
21. Squamous Cell Carcinoma
⢠Wide excision is Rx of choice
⢠NCCN 2013 guideline : hand region
⢠Resection margin
â Size < 6 mm : margin 4-6 mm
â Size >/= 6 mm : margin 10 mm
⢠Clinical LN or imaging LN positive : FNA
⢠If positive FNA >> LN dissection
23. Basal Cell Carcinoma
⢠2nd most common malignant on hand (Vandeweye
and Herszkowicz 2003 : < 1% of BCAA all cases)
⢠Sun exposure area
⢠Mostly presented as chronic ulceration
(Vandeweye and Herszkowicz 2003)
⢠Ulcerated skin with pearly elevated edges
⢠Rarely metastasize
⢠Confirm Dx by biopsy (excisional or incisional)
24. Basal Cell Carcinoma
⢠WLE is Rx of choice
⢠NCCN guideline 2013
⢠Resection margin
â Size < 6 mm : margin
4 mm
â Size >/= 6 mm :
margin 10 mm
25. Melanoma in Hand
⢠Durbec et al. 2012
â Incidence of subungual cutanous melanoma is
0.1/100000
â Blacks = Whites
â Predominate location at subungual, rarely in palm
â UV light irradiation, trauma : still inconclusive risk
factor
â Poorer prognosis than other location of melanoma
due to more advanced stage of tumour at first
diagnosis
26. Melanoma in Hand
⢠Rx from NCCN 2013 guideline
⢠Main Rx still be aggressive surgical resection
⢠Resection margin :
â Insitu : 0.5-1 cm
â Thick < / = 1 mm : 1 cm
â Thick 1.01-2 mm : 1-2 cm
â Thick 2.01-4 mm : 2 cm
â Thick > 4 mm
: 2 cm
27. Melanoma in Hand
⢠Rx from NCCN 2013 guideline
⢠SLNB should be done in all cases
â Stage IA (thick 0.76-1 mm)
â Subungual melanoma (Difficult to evaluate thickness)
⢠Work up distant metastasis such as CT chest
and abdomen : Stage III (node positive both form
FNA and Clinical)
28. Tumour of Cartilage & Bone in Hand
⢠Enchondroma : most common of bone tumour
in hand
⢠Osteochondroma
⢠Chondrosarcoma
29. Enchondroma
⢠Most common primary
tumour in the bone of the
hand (Green : 35% of
all, 90% of bone tumour in
hand)
⢠Proximal phalanx >
metacarpal > distal
phalanx
⢠Common present with
pain and edema (pathologic
fracture)
⢠X-ray : radiolucent lesion
with cortical thinning and
popcorn calcification
30. Enchondroma
⢠Solitary lesion 1-5% transform to
chondrosarcoma (Muller et al. 2004)>> *need F/U*
⢠Rx :
â Small & asymptomatic with typical X ray >>
conservative and observation
â Large or symptomatic or atypical X-ray >> biopsy
or curettage
⢠4.5% recurrence after curettage
31. Periosteal Chondroma
⢠Uncommon
⢠Confused
â X-ray like enchondroma
â Histology like chondrosarcoma
⢠Men in 20s â 30s
⢠Metaphyseal-diaphyseal junction of
phalanges
⢠Benign but need marginal resection
with overlying periosteum
⢠< 4% local recurrence
32. Osteochondroma
⢠Most common benign
bone tumour, but not
in hand region
⢠Distal aspect of
proximal phalanx in
20s-30s
⢠X-ray : osseous growth
with cartilaginous cap
from physis area
33. Osteochondroma
⢠1-2% malignant transformation in single lesion
(Kitsoulis et al. 2008)
⢠10-25% malignant degeneration in mutiple
lesion case (Neligan)
⢠Rx :
â Asymptomatic : observation
â Impaired function : excision
34. Chondrosarcoma
⢠Most common primary malignant bone tumour in
hand
⢠Slowly growth, firm and painful mass
⢠Proximal phalanx (Patil et al. 2003) and metacarpal
⢠X-ray : lytic lesion with cortical destruction and
soft tissue destruction with poor defined border
⢠10% risk for metastasis (Muller et al. 2004 : less than
other location,18%)